Wakefield Asset Management LLLP
Source: SEC Form 13F · as of Mar 2026Wakefield Asset Management LLLP holds 12 biotech & pharma companies tracked by BioSniper, totaling $17.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$17.3M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 30,860 | $4.3M |
| BMYBRISTOL MYERS SQUIBB CO | 41,349 | $2.5M |
| ABBVAbbVie Inc. | 7,822 | $1.7M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 30,332 | $1.7M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 52,135 | $1.3M |
| ELVElevance Health Inc. | 4,000 | $1.2M |
| ANIPANI PHARMACEUTICALS INC | 14,078 | $1.1M |
| MRKMerck & Co., Inc. | 8,331 | $1.0M |
| AMGNAMGEN INC | 2,008 | $707K |
| PMPhilip Morris International Inc | 4,008 | $663K |
| CAHCardinal Health Inc. | 2,978 | $629K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,276 | $570K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.